27 Sep Inside the Patient Entrepreneur’s Mind: Ira Spector, PhD by SFA Therapeutics in NewsComments Read More... Read More
09 Sep Innovations in Dermatological Sciences by SFA Therapeutics in NewsComments Read More... Read More
05 Aug SFA Therapeutics, Inc. Requests FDA Orphan Drug Designation (ODD) for SFA001 for Treatment of Hepatocellular Carcinoma (HCC) by SFA Therapeutics in NewsComments Read More... Read More
31 May SFA Therapeutics to Present Human Psoriasis Data for Microbiome-based Drug (SFA002) at the Global Biotech Entrepreneur Forum and the BIO International Convention by SFA Therapeutics in NewsComments Read More... Read More
31 May SFA Therapeutics to Present Human Psoriasis Data for Microbiome-based Drug (SFA002) at the Global Biotech Entrepreneur Forum and the BIO International Convention by SFA Therapeutics in NewsComments Read More... Read More
19 Mar SFA Therapeutics Wins Second Key U.S. Patent For Treatment of Chronic Liver Diseases by SFA Therapeutics in NewsComments Read More... Read More
02 Mar Helsinn Investment Fund: 10 finalists for Lyfebulb-Helsinn innovation summit & awards in oncology by SFA Therapeutics in NewsComments Read More... Read More
05 Dec SFA Therapeutics Wins U.S. Patent for Use of Short Chain Fatty Acids in Cancer Prevention by SFA Therapeutics in NewsComments Read More... Read More
23 Aug And the 2018 Stellar StartUps Finalists are by SFA Therapeutics in NewsComments Read More... Read More
22 Jan CEO LEADERSHIP SERIES: IRA C. SPECTOR, PH.D., CEO, SFA THERAPEUTICS by SFA Therapeutics in NewsComments Read More... Read More